Diisopropylethylamine → 2-bromo-N-[4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-yl]-isonicotinamide

To a stirred solution of 0.99 g (4.92 mmol) 2-bromo-isonicotinic acid in 40 ml THF were added 2.16 g (5.67 mmol) HATU and 0.97 ml (5.67 mmol) N-ethyldiisopropylamine and stirring continued at room temperature for 1 h. A solution of 1.00 g (3.78 mmol) 4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-ylamine in 20 ml dioxane and 4 ml DMF was then added and stirring continued at room temperature for 48 h. The reaction mixture was then poured into aqueous sodium bicarbonate solution and extracted three times with dichloromethane. The combined organic phases were washed with 1 M hydrochloric acid, then dried over sodium sulfate and concentrated in vacuo. Flash chromatography (acetone/hexane 1/4) followed by trituration in ether afforded 500 mg (29%) 2-bromo-N-[4-methoxy-7-(tetrahydro-pyran-2-yl)-benzothiazol-2-yl]-isonicotinamide as a light yellow crystalline solid. ES-MS m/e (%): 450 (M{81Br}+H+, 100), 448 (M{79Br}+H+, 80).

1. stirringstirring
2. waitcontinued at room temperature for 48 h
3. extractionextracted three times with dichloromethane
4. washThe combined organic phases were washed with 1 M hydrochloric acid
5. dry with materialdried over sodium sulfate
6. concentrationconcentrated in vacuo

ORD record

ord-23fe45ec78f048dc8a93fe2e5c26eda9

Source dataset

uspto-grants-2004_05

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US06734179B2